May 2, 2023
Homozygous immune cell therapy In vivo, it is invested in Shita Pharmaceutical "コヅリリ-R"が The patient's cell is the same as the person. New immune cells are generated for treatment. The main role of red blood cells, liver cells, white blood cells, etc. The generation of pharmaceutical products, the isolation of drugs, the isolation of drugs, the isolation of drugs, the isolation of drugs, the isolation of drugs、 The cells of the two parties are combined, and the characteristics of the two parties are affected.、 The cells of the new Tana species are generated. The patient's cells generate surutame and refuse to respond. The danger is very small. Zi Zuori
